-
1دورية أكاديمية
المصدر: Current Oncology, 29 (6), 4178-4184 (2022)
مصطلحات موضوعية: PARP inhibitors, RAD51B, prostate cancer, Circulating Tumor DNA, DNA-Binding Proteins, Indoles, Poly(ADP-ribose) Polymerase Inhibitors, RAD51B protein, human, rucaparib, Prostate-Specific Antigen, DNA-Binding Proteins/therapeutic use, Humans, Indoles/therapeutic use, Male, Poly(ADP-ribose) Polymerase Inhibitors/pharmacology, Poly(ADP-ribose) Polymerase Inhibitors/therapeutic use, Prostatic Neoplasms, Castration-Resistant/drug therapy, Prostatic Neoplasms, Castration-Resistant/genetics, Prostatic Neoplasms, Castration-Resistant, Oncology, Human health sciences, Sciences de la santé humaine, Oncologie
Relation: https://www.mdpi.com/1718-7729/29/6/333/pdf; urn:issn:1718-7729
URL الوصول: https://orbi.uliege.be/handle/2268/295453
-
2دورية أكاديميةSprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
المؤلفون: Patel, Rachana, Fleming, Janis, Mui, Ernest, Loveridge, Carolyn, Repiscak, Peter, Blomme, Arnaud, Harle, Victoria, Salji, Mark, Ahmad, Imran, Teo, Katy, Hamdy, Freddie C., Hedley, Ann, van den Broek, Niels, Mackay, Gillian, Edwards, Joanne, Sansom, Owen J., Leung, Hing Y.
المصدر: EMBO Molecular Medicine, 10 (4) (2018)
مصطلحات موضوعية: Animals, Humans, Interleukin-6/metabolism, Intracellular Signaling Peptides and Proteins/genetics/metabolism, Male, Membrane Proteins/genetics/metabolism, Mice, Nude, Phenylenediamines/therapeutic use, Prostatic Neoplasms, Castration-Resistant/drug therapy/metabolism, Protein-Serine-Threonine Kinases, Real-Time Polymerase Chain Reaction, Receptor, ErbB-2/genetics/metabolism, Receptors, Scavenger/metabolism, Scavenger Receptors, Class B/antagonists & inhibitors, Signal Transduction/drug effects/physiology, Sulfonamides/therapeutic use, androgen receptor, cholesterol, interleukin 6, prostate cancer, scavenger receptor B1, Life sciences, Biochemistry, biophysics & molecular biology, Sciences du vivant, Biochimie, biophysique & biologie moléculaire
Relation: urn:issn:1757-4676; urn:issn:1757-4684
URL الوصول: https://orbi.uliege.be/handle/2268/248286
-
3
المؤلفون: Cora N, Sternberg, Karim, Fizazi, Fred, Saad, Neal D, Shore, Ugo, De Giorgi, David F, Penson, Ubirajara, Ferreira, Eleni, Efstathiou, Katarzyna, Madziarska, Michael P, Kolinsky, Daniel I G, Cubero, Bettina, Noerby, Fabian, Zohren, Xun, Lin, Katharina, Modelska, Jennifer, Sugg, Joyce, Steinberg, Maha, Hussain, R, Waterhouse
المصدر: Sternberg, C N, Fizazi, K, Saad, F, Shore, N D, de Giorgi, U, Penson, D F, Ferreira, U, Efstathiou, E, Madziarska, K, Kolinsky, M P, Cubero, D I G, Noerby, B, Zohren, F, Lin, X, Modelska, K, Sugg, J, Steinberg, J, Hussain, M & The PROSPER Investigators 2020, ' Enzalutamide and survival in nonmetastatic, castration-resistant prostate cancer ', New England Journal of Medicine, vol. 382, no. 23, pp. 2197-2206 . https://doi.org/10.1056/NEJMoa2003892
New England Journal of Medicine, 382(23), 2197-2206. MASSACHUSETTS MEDICAL SOCمصطلحات موضوعية: Oncology, Male, medicine.medical_specialty, Prostate-Specific Antigen/blood, MEDLINE, Kaplan-Meier Estimate, 030204 cardiovascular system & hematology, Castration resistant, Adenocarcinoma, law.invention, Placebos, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Randomized controlled trial, Double-Blind Method, law, Adenocarcinoma/drug therapy, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Nitriles, Phenylthiohydantoin, medicine, Enzalutamide, Humans, 030212 general & internal medicine, Survival analysis, Aged, Prostatic Neoplasms, Castration-Resistant/drug therapy, business.industry, Phenylthiohydantoin/adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Androgen Antagonists, General Medicine, Middle Aged, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Clinical trial, Kallikreins/blood, Prostatic Neoplasms, Castration-Resistant, Darolutamide, chemistry, Benzamides, Kallikreins, business, Androgen Antagonists/therapeutic use
وصف الملف: application/pdf
-
4
المؤلفون: Piet Ost, Jörgen Van Bauwel, Valérie Fonteyne, Renée Bultijnck, Karel Decaestecker, Noëmi Borrey, Elke Rammant, Adelheid Steyaert, Benedicte Deforche, Nicolaas Lumen, Maarten Lievens
المساهمون: Movement and Nutrition for Health and Performance, Movement and Sport Sciences
المصدر: World Journal of Urology. 39:357-364
مصطلحات موضوعية: Male, Nephrology, medicine.medical_specialty, Urology, medicine.medical_treatment, 030232 urology & nephrology, Castrate-resistant prostate cancer, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Dose escalation, Humans, Dosing, Neoplasm Metastasis, Medical prescription, Aged, Prostatic Neoplasms, Castration-Resistant/drug therapy, business.industry, Middle Aged, medicine.disease, Combined Modality Therapy, Exercise Therapy/methods, 030220 oncology & carcinogenesis, Hormone therapy, Exercise prescription, business
-
5
المؤلفون: Linder, Simon, Hoogstraat, Marlous, Stelloo, Suzan, Eickhoff, Nils, Schuurman, Karianne, de Barros, Hilda, Alkemade, Maartje, Bekers, Elise M., Severson, Tesa M., Sanders, Joyce, Huang, Chia Chi Flora, Morova, Tunc, Altintas, Umut Berkay, Hoekman, Liesbeth, Kim, Yongsoo, Baca, Sylvan C., Sjöström, Martin, Zaalberg, Anniek, Hintzen, Dorine C., de Jong, Jeroen, Kluin, Roelof J.C., de Rink, Iris, Giambartolomei, Claudia, Seo, Ji Heui, Pasaniuc, Bogdan, Altelaar, Maarten, Medema, René H., Feng, Felix Y., Zoubeidi, Amina, Freedman, Matthew L., Wessels, Lodewyk F.A., Butler, Lisa M., Lack, Nathan A., van der Poel, Henk, Bergman, Andries M., Zwart, Wilbert, Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics
المساهمون: Afd Biomol.Mass Spect. and Proteomics, Biomolecular Mass Spectrometry and Proteomics, Chemical Biology, Pathology, CCA - Cancer biology and immunology, Ethics, Law & Medical humanities, APH - Quality of Care, Urology
المصدر: Cancer Discovery, 12(9), 2074-2097. American Association for Cancer Research Inc.
Cancer Discovery, 12(9), 2074. American Association for Cancer Research Inc.
Linder, S, Hoogstraat, M, Stelloo, S, Eickhoff, N, Schuurman, K, de Barros, H, Alkemade, M, Bekers, E M, Severson, T M, Sanders, J, Huang, C-C F, Morova, T, Altintas, U B, Hoekman, L, Kim, Y, Baca, S C, Sjöström, M, Zaalberg, A, Hintzen, D C, de Jong, J, Kluin, R J C, de Rink, I, Giambartolomei, C, Seo, J-H, Pasaniuc, B, Altelaar, M, Medema, R H, Feng, F Y, Zoubeidi, A, Freedman, M L, Wessels, L F A, Butler, L M, Lack, N A, van der Poel, H, Bergman, A M & Zwart, W 2022, ' Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence ', Cancer discovery, vol. 12, no. 9, pp. 2074-2097 . https://doi.org/10.1158/2159-8290.CD-21-0576
Cancer Discov
Cancer discovery, 12(9)
Cancer discovery, vol 12, iss 9
Cancer discovery, 12(9), 2074-2097. American Association for Cancer Research Inc.مصطلحات موضوعية: Urologic Diseases, Epigenomics, Male, Aging, Oncology and Carcinogenesis, ARNTL Transcription Factors/genetics, Drug Resistance, Drug Resistance, Neoplasm/genetics, SDG 3 – Goede gezondheid en welzijn, Castration-Resistant, Article, Cell Line, Androgen, SDG 3 - Good Health and Well-being, Cell Line, Tumor, Receptors, Nitriles, Phenylthiohydantoin, Taverne, 2.1 Biological and endogenous factors, Humans, Aetiology, Androgens/pharmacology, Cancer, Prostatic Neoplasms, Castration-Resistant/drug therapy, Castration-Resistant/drug therapy, Tumor, Nitriles/therapeutic use, Neoplasm/genetics, Prostate Cancer, Aryl Hydrocarbon Receptor Nuclear Translocator, Androgen/genetics, Prostatic Neoplasms, ARNTL Transcription Factors, Receptors, Androgen/genetics, Circadian Rhythm, Prostatic Neoplasms, Castration-Resistant, Oncology, 5.1 Pharmaceuticals, Drug Resistance, Neoplasm, Receptors, Androgen, Benzamides, Androgens, Neoplasm, Development of treatments and therapeutic interventions, Biotechnology
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039c32e9b5e18899785f8d02a47ca186
https://doi.org/10.1158/2159-8290.cd-21-0576 -
6
المساهمون: Chemical Biology
المصدر: Endocrine-Related Cancer
Endocrine-related cancer, 26(1), R31-R52. BioScientifica Ltd.مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Endocrinology, Diabetes and Metabolism, Drug Resistance, Review, Drug resistance, Docetaxel, Treatment resistance, androgen deprivation therapy, Drug Resistance, Neoplasm/drug effects, MCRPC, SDG 3 – Goede gezondheid en welzijn, Androgen deprivation therapy, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Neoplasm/drug effects, androgen receptor, Castration-Resistant/drug therapy, Phenylthiohydantoin/analogs & derivatives, 3. Good health, Prostatic Neoplasms, Castration-Resistant, 030220 oncology & carcinogenesis, Benzamides, medicine.drug, medicine.medical_specialty, Translational research, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Enzalutamide, Humans, Prostatic Neoplasms, Castration-Resistant/drug therapy, business.industry, biomarkers, Prostatic Neoplasms, medicine.disease, mutations, Androgen receptor, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::357bc7afdab1ba7fb514f96f883fe2d1
https://research.tue.nl/en/publications/e684cbca-aa8a-4687-a92c-cecbb6d86f63 -
7
المؤلفون: Stephane OUDARD, David Olmos Hidalgo, María J. Ribal, Tomasz Drewa, ARANZAZU GONZALEZ-DEL-ALBA, Marcin Słojewski, Susan Ellard, Louis Lacombe, PABLO MAROTO REY, Javier Angulo, Adel Izmailov, Gwenaelle Gravis, Lisa Horvath, Boris Hadaschik, Ernesto Sanchez Sanchez, Florence Joly, Emmanuelle Bompas, Anders Kjellman, Hakim MAHAMMEDI, Arnauld VILLERS, Jose Luis Perez-Gracia, Carlos Ferrer Albiach
المصدر: The New England Journal of Medicine, 378, 15, pp. 1408-1418
Poulsen, M H & SPARTAN Investigators 2018, ' Apalutamide treatment and metastasis-free survival in prostate cancer ', New England Journal of Medicine, vol. 378, no. 15, pp. 1408-1418 . https://doi.org/10.1056/NEJMoa1715546
The New England Journal of Medicine, 378, 1408-1418مصطلحات موضوعية: Male, Oncology, Medizin, 030232 urology & nephrology, prostatic neoplasms, law.invention, Metastasis, neoplasm metastasis, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Randomized controlled trial, law, middle aged, Thiohydantoins/adverse effects, 80 and over, double-blind method, 030212 general & internal medicine, Neoplasm Metastasis, humans, Aged, 80 and over, Medicine (all), Apalutamide, thiohydantoins, General Medicine, Middle Aged, Prostatic Neoplasms, Castration-Resistant, aged, Prostate-specific antigen, Darolutamide, Thiohydantoins, 030220 oncology & carcinogenesis, Disease Progression, exanthema, Exanthema/chemically induced, Androgen Antagonists/adverse effects, proportional hazards models, medicine.medical_specialty, Randomization, disease-free survival, Urology, Neoplasm Metastasis/prevention & control, MEDLINE, adenocarcinoma, aged, 80 and over, androgen antagonists, disease progression, male, prostate-specific antigen, prostatic neoplasms, castration-resistant, Adenocarcinoma, Disease-Free Survival, 03 medical and health sciences, Double-Blind Method, Adenocarcinoma/drug therapy, Internal medicine, Urological cancers Radboud Institute for Molecular Life Sciences [Radboudumc 15], medicine, Humans, Aged, Proportional Hazards Models, ta3126, Prostatic Neoplasms, Castration-Resistant/drug therapy, business.industry, Androgen Antagonists, Exanthema, Prostate-Specific Antigen, medicine.disease, Clinical trial, chemistry, Metastasis free survival, castration-resistant, business
وصف الملف: application/pdf
-
8
المؤلفون: Thierry Gil, Peter Schatteman, Marylene Clausse, Jan Van Haverbeke, Joanna Van Erps, Jeroen Mebis, Wim Demey, Marika Rasschaert, Dirk Schrijvers, Lionel D'Hondt, Els Everaert, W. Wynendaele, Bertrand Filleul, Sylvie Rottey, Filip Van Aelst, Joanna Vermeij, Fransien Van Hende, Patrick Werbrouck, Jean-Charles Goeminne, Charles Van Praet, Gino Pelgrims, Nicolaas Lumen, Jolanda Verheezen, Jean Pascal Machiels, Denis Schallier
المساهمون: Laboratory of Molecular and Medical Oncology
المصدر: Clinical Genitourinary Cancer
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Taxoids/therapeutic use, Urology, Abiraterone Acetate, Abiraterone Acetate/therapeutic use, Prednisone/therapeutic use, Docetaxel, chemotherapy, survival, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, Humans, Medicine, Enzalutamide, 030212 general & internal medicine, Survival analysis, Aged, Proportional Hazards Models, Retrospective Studies, Prostatic Neoplasms, Castration-Resistant/drug therapy, Univariate analysis, business.industry, Proportional hazards model, Abiraterone acetate, Prostatic Neoplasms, Retrospective cohort study, Prognosis, medicine.disease, Survival Analysis, Surgery, Prostatic Neoplasms, Castration-Resistant, Treatment Outcome, ROC Curve, chemistry, 030220 oncology & carcinogenesis, Prednisone, Taxoids, Human medicine, business, steroids, medicine.drug
-
9مورد إلكتروني
المؤلفون: Linder, Simon, van der Poel, Henk G., Bergman, Andries M., Zwart, Wilbert, Prekovic, Stefan
المصدر: Endocrine-related cancer vol.26 (2019) nr.1 p.R31-R52 [ISSN 1351-0088]
مصطلحات الفهرس: Androgen deprivation therapy, Androgen receptor, Biomarkers, Docetaxel, Enzalutamide, MCRPC, Mutations, Prostate cancer, Treatment resistance, androgen deprivation therapy, biomarkers, mCRPC, prostate cancer, androgen receptor, mutations, docetaxel, enzalutamide, treatment resistance, Humans, Drug Resistance, Neoplasm/drug effects, Male, Phenylthiohydantoin/analogs & derivatives, Prostatic Neoplasms, Castration-Resistant/drug therapy, SDG 3 - Good Health and Well-being, Tijdschriftartikel, Article
URL:
https://research.tue.nl/en/publications/e684cbca-aa8a-4687-a92c-cecbb6d86f63 https://pure.tue.nl/ws/files/111513632/_14796821_Endocrine_Related_Cancer_Enzalutamide_therapy_for_advanced_prostate_cancer_efficacy_resistance_and_beyond.pdf https://pure.tue.nl/ws/files/111513632/_14796821_Endocrine_Related_Cancer_Enzalutamide_therapy_for_advanced_prostate_cancer_efficacy_resistance_and_beyond.pdf -
10مورد إلكتروني
المؤلفون: Smith, Matthew R, Saad, Fred, Chowdhury, Simon, Oudard, Stéphane, Hadaschik, Boris A, Graff, Julie N, Olmos, David, Mainwaring, Paul N, Lee, Ji Youl, Uemura, Hiroji, Lopez-Gitlitz, Angela, Trudel, Géralyn C, Espina, Byron M, Shu, Youyi, Park, Youn C, Rackoff, Wayne R, Yu, Margaret K, Small, Eric J, Mainwaring, Paul, Horvath, Lisa, Nott, Louise, Brasso, Klaus, Harving, Niels, Holm-Nielsen, Anders, Poulsen, Mads, Pachynski, Russell, Ahaghotu, Chiledum, Kemeny, Margaret
المصدر: Smith , M R , Saad , F , Chowdhury , S , Oudard , S , Hadaschik , B A , Graff , J N , Olmos , D , Mainwaring , P N , Lee , J Y , Uemura , H , Lopez-Gitlitz , A , Trudel , G C , Espina , B M , Shu , Y , Park , Y C , Rackoff , W R , Yu , M K , Small , E J , SPARTAN Investigators , Mainwaring , P , Horvath , L , Nott , L , Brasso , K , Harving , N , Holm-Nielsen , A , Poulsen , M , Pachynski , R , Ahaghotu , C & Kemeny , M 2018 , ' Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer ' , The New England Journal of Medicine , vol. 378 , no. 15 , pp. 1408-1418 .
مصطلحات الفهرس: Adenocarcinoma/drug therapy, Aged, Aged, 80 and over, Androgen Antagonists/adverse effects, Disease Progression, Disease-Free Survival, Double-Blind Method, Exanthema/chemically induced, Humans, Male, Middle Aged, Neoplasm Metastasis/prevention & control, Proportional Hazards Models, Prostate-Specific Antigen, Prostatic Neoplasms, Castration-Resistant/drug therapy, Thiohydantoins/adverse effects, article
URL:
https://curis.ku.dk/portal/da/publications/apalutamide-treatment-and-metastasisfree-survival-in-prostate-cancer(0ee7071d-ed4f-420a-9488-f6cda3ed1c97).html https://doi.org/10.1056/NEJMoa1715546